These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 3502064)

  • 1. Abnormalities in corticotropin-releasing hormone (CRH) in Alzheimer's disease and other human disorders.
    De Souza EB; Whitehouse PJ; Price DL; Vale WW
    Ann N Y Acad Sci; 1987; 512():237-47. PubMed ID: 3502064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Corticotropin-releasing hormone (CRH) receptors in brain.
    De Souza EB; Battaglia G
    Adv Exp Med Biol; 1988; 245():123-36. PubMed ID: 2852454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CRH defects in Alzheimer's and other neurologic diseases.
    de Souza EB
    Hosp Pract (Off Ed); 1988 Sep; 23(9):59-71. PubMed ID: 2901426
    [No Abstract]   [Full Text] [Related]  

  • 4. Reciprocal changes in corticotropin-releasing factor (CRF)-like immunoreactivity and CRF receptors in cerebral cortex of Alzheimer's disease.
    De Souza EB; Whitehouse PJ; Kuhar MJ; Price DL; Vale WW
    Nature; 1986 Feb 13-19; 319(6054):593-5. PubMed ID: 3003585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of CRH in the pathogenesis of dementia of Alzheimer's type and other dementias.
    Rehman HU
    Curr Opin Investig Drugs; 2002 Nov; 3(11):1637-42. PubMed ID: 12476966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reductions in corticotropin releasing factor-like immunoreactivity in cerebral cortex in Alzheimer's disease, Parkinson's disease, and progressive supranuclear palsy.
    Whitehouse PJ; Vale WW; Zweig RM; Singer HS; Mayeux R; Kuhar MJ; Price DL; De Souza EB
    Neurology; 1987 Jun; 37(6):905-9. PubMed ID: 3495748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reductions in acetylcholine and nicotine binding in several degenerative diseases.
    Whitehouse PJ; Martino AM; Marcus KA; Zweig RM; Singer HS; Price DL; Kellar KJ
    Arch Neurol; 1988 Jul; 45(7):722-4. PubMed ID: 3390025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cortical concentrations of corticotropin-releasing hormone and its receptor in Alzheimer type dementia and major depression.
    Leake A; Perry EK; Perry RH; Fairbairn AF; Ferrier IN
    Biol Psychiatry; 1990 Oct; 28(7):603-8. PubMed ID: 2171685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distribution and quantification of corticotropin-releasing hormone (CRH) in the brain of the teleost fish Oreochromis mossambicus (tilapia).
    Pepels PP; Meek J; Wendelaar Bonga SE; Balm PH
    J Comp Neurol; 2002 Nov; 453(3):247-68. PubMed ID: 12378586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Corticotropin-releasing hormone mRNA levels in the paraventricular nucleus of patients with Alzheimer's disease and depression.
    Raadsheer FC; van Heerikhuize JJ; Lucassen PJ; Hoogendijk WJ; Tilders FJ; Swaab DF
    Am J Psychiatry; 1995 Sep; 152(9):1372-6. PubMed ID: 7653697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Corticotropin-releasing hormone protects neurons against insults relevant to the pathogenesis of Alzheimer's disease.
    Pedersen WA; McCullers D; Culmsee C; Haughey NJ; Herman JP; Mattson MP
    Neurobiol Dis; 2001 Jun; 8(3):492-503. PubMed ID: 11442356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peptides in the neocortex in Alzheimer's disease and ageing.
    Ferrier IN; Leake A
    Psychoneuroendocrinology; 1990; 15(2):89-95. PubMed ID: 1972799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Corticotropin-releasing hormone (CRH) is decreased in the basal ganglia in Huntington's disease.
    De Souza EB; Whitehouse PJ; Folstein SE; Price DL; Vale WW
    Brain Res; 1987 Dec; 437(2):355-9. PubMed ID: 2893655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alzheimer's disease and corticotropin-releasing factor.
    Swanson LW
    JAMA; 1985 Dec; 254(21):3085-6. PubMed ID: 3877183
    [No Abstract]   [Full Text] [Related]  

  • 15. Corticotropin releasing factor in Alzheimer's disease.
    Charlton BG
    Lancet; 1987 Feb; 1(8528):334. PubMed ID: 2880151
    [No Abstract]   [Full Text] [Related]  

  • 16. Cerebrospinal fluid concentrations of corticotropin-releasing hormone (CRH) and corticotropin (ACTH) are reduced in patients with Alzheimer's disease.
    May C; Rapoport SI; Tomai TP; Chrousos GP; Gold PW
    Neurology; 1987 Mar; 37(3):535-8. PubMed ID: 3029628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Colocalization of corticotropin-releasing hormone and oestrogen receptor-alpha in the paraventricular nucleus of the hypothalamus in mood disorders.
    Bao AM; Hestiantoro A; Van Someren EJ; Swaab DF; Zhou JN
    Brain; 2005 Jun; 128(Pt 6):1301-13. PubMed ID: 15705605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nurr1 in Parkinson's disease and related disorders.
    Chu Y; Le W; Kompoliti K; Jankovic J; Mufson EJ; Kordower JH
    J Comp Neurol; 2006 Jan; 494(3):495-514. PubMed ID: 16320253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The neuroprotective actions of corticotropin releasing hormone.
    Bayatti N; Behl C
    Ageing Res Rev; 2005 May; 4(2):258-70. PubMed ID: 16046283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. On the structural form of iron in ferritin cores associated with progressive supranuclear palsy and Alzheimer's disease.
    Dobson J
    Cell Mol Biol (Noisy-le-grand); 2001; 47 Online Pub():OL49-50. PubMed ID: 11936873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.